REQUEST A DEMO
Total
USD $0.00
Search more companies

Remidex Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Remidex Pharma Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Remidex Pharma Private Limited is an unlisted company, incorporated on 15/06/1981. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U24231KA1981PTC004260 and registration number is 004260. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate
Bangalore; Karnataka; Postal Code: 560058

Contact Details: Purchase the Remidex Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Remidex Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Remidex Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Remidex Pharma Private Limited report to view the information.
Incorporation Date:
June 15, 1981
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Remidex Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
72.73%
Total operating revenue
72.73%
Operating profit (EBIT)
15.85%
EBITDA
7.47%
Net Profit (Loss) for the Period
12.46%
Total assets
-8.99%
Total equity
-52.4%
Operating Profit Margin (ROS)
7.93%
Net Profit Margin
7.98%
Return on Equity (ROE)
-50.22%
Debt to Equity Ratio
113.67%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?